XTalks

MARCH 22, 2023

Within 2009 and 2010, Swiss pharmas Roche and Novartis acquired Genentech and Alcon , respectively. Roche had been a majority stakeholder in Genentech since 1990. In addition, nearly half of all new drugs launched between 2020 and 2021 came with a price tag of $150,000 per year, or more.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Drug Discovery World

NOVEMBER 13, 2023

Next, the keynote presentation will take place by Andrew Kosky, PhD, Sr Director, Technical Development, Genentech. Fabian Mohr, PhD, Vice President Research & Development, IBA Lifesciences, on: ‘Developing a robust affinity tag platform using engineered streptavidin’.

Protein 59

Protein Antibody Engineer Scientist 59

Drug Discovery World

NOVEMBER 9, 2023

Esperanza Rivera de Torre, PhD, Assistant Professor, Center for Antibody Technologies, Department of Bioengineering, Technical University of Denmark, on: ‘Venom on demand: optimising snake toxin yield, folding, and purity in E coli and P pastoris with biotinylation, solubility, and purification tags’.

Engineer 52

Engineer Antibody Protein In-Vivo 52